Forgot Password?

Pain Medication OTC Manufacturing in Australia: Market Research Report

Market Research • Market Size • Industry Statistics • Industry Analysis • Industry Trends

Pain Medication OTC Manufacturing Market Research Report | Life Sciences | OTC Medicines | 2016

Relieved: Revenue grows as Australia's aging population increasingly seek industry products

IBISWorld’s Pain Medication OTC Manufacturing market research report is a comprehensive guide to market size and growth prospects. Our industry reports offer strategic industry analysis of the factors influencing companies, including new product developments, economic, lifestyle and demographic influences, distribution and supply chain factors and pricing issues. Full analysis accompanies our data forecasts to illustrate how the market responds to emerging industry trends.

Report Snapshot
Market Share of Companies
GlaxoSmithKline GlaxoSmithKline market share
Industry Statistics & Market Size
Add to Cart
Annual Growth 11-16
Add to Cart
Annual Growth 16-21
Add to Cart
Add to Cart
Add to Cart
Add to Cart
What is the Pain Medication OTC Manufacturing industry?

Compared with the overall Pharmaceutical Product Manufacturing industry, the Pain Medication OTC Manufacturing industry is relatively less capital-intensive as it does not have the same need for facilities capable of producing high-cost, high technology drugs. Nevertheless it still has a moderate level of capital intensity with capital used to build and maintain manufacturing, formulation and packaging facilities. At the same time, the industry has a relatively high level of labour intensity, as the manufacturing processes involve highly skilled labour. In 2015-16 the industry will spend $6.72 on labour for each dollar spent on capital investments... purchase to read more


Industry ProductsRelated ReportsTable of Contents
Major products in this industry
SalicylatesPropionic acid derivativesAcetaminophensOther non-steroidal anti-inflammatory drugs

View Sample
Select Clients